BIOTECHNOLOGY IN HEALTHCARE:PRODUCT AND MARKET REVIEW

Report Code: HLC005A

Publish Date: Nov 2003

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Explains the concept and role of biotechnology based products in pharmaceutical industry. 
  • Analysis of the benchmarking categories: Therapeutic proteins, gene therapies, blood components and derivatives, vaccines, allergenics, devices. 
  • Critical analysis of marketed products and R&D products in each category. 
  • Market trends. 
  • Description of the key stages in the drug development pathway that a new drug candidate has to go through. 
  • In depth evaluation of the main technologies in biotechnology research: bioinformatics, genomics, microarrays, proteomics, and pharmacogenomics. 
  • Overview of biotechnology based pharmaceutical industry in the U.S., Europe, Canada and Asia/Pacific focused on key therapy areas, promising approved products, technologies and regional product approval agencies/guidelines. 
  • Analysis of key medical conditions that drive biotechnology based research and drug development, comparison with available standard hormonal/chemical treatments for the same. 
  • Company focused evaluation of major players in the industry - forecasts and business strategies.

INTRODUCTION

OBJECTIVES OF REVIEW
 
This review provides an in-depth look at the most promising major biologics (blood, blood components and derivatives, allergenics and vaccines) that include biotechnology based drugs and products (therapeutic proteins, recombinant DNA vaccines, gene therapies, and devices).
 
Drivers and resistors of the global biotech pharma market have been discussed with reference to product, region and technology specific factors. Individual product profiles are included. We explore how biotechnology based pharma industry works, has grown over the years and the key factors that contribute to its growth. While the industry is undeniably global, it is impossible to understand it without regional knowledge. Therefore, we will explore Canadian, European and Asia/Pacific markets besides U.S. All in all, this review will serve as a one-stop data bank for biotech enthusiasts.
 
AUDIENCE FOR REVIEW
 
The advent of biotechnology has allowed for tremendous strides in the discovery, development, and commercialization of novel therapeutics, vaccines and new chemical entities by both biotechnology and pharma companies. While biotechnology offers research institutions and companies a myriad of options for the development of these therapeutics, it has become clear that two development platforms have taken on a leading role. Therapeutic proteins and therapeutic antibodies collectively comprise almost 75% of the biotechnology drugs currently on the market and the new chemical entities, or NCEs, rule rest of the market. With this review, we will provide background on these development platforms, their respective applications, and potential market opportunities for drugs emerging from them.
 
This review will define the drivers and resistors of the global biotech pharma market with reference to product, region and technology specific factors. It explores how biotechnology based pharmaceutical industry works and has grown over the years.
 
The information and analysis offered through this review is an important asset in decision-making for managers and consultants in the pharmaceutical and biotechnology industry and for young entrepreneurs planning for biotech startup ventures.

SCOPE AND CONTENT

This review provides a comprehensive evaluation of the most promising major biologics (blood, blood components and derivatives, allergenics and vaccines) that include biotechnology based drugs and products (therapeutic proteins, recombinant DNA vaccines, gene therapies, devices).
 
This review gives you access to:
 
  • Explanation of the concept and role of biotechnology based products in pharmaceutical industry. 
  • Analysis of the benchmarking categories: Therapeutic proteins, gene therapies, blood components and derivatives, vaccines, allergenics, devices. 
  • Critical analysis of marketed products and R&D products in each category. 
  • Market trends. 
  • Description of the key stages in the drug development pathway that a new drug candidate has to go through. 
  • In depth evaluation of the main technologies in biotechnology research: bioinformatics, genomics, microarrays, proteomics, and pharmacogenomics. 
  • Overview of biotechnology based pharmaceutical industry in the U.S., Europe, Canada and Asia/Pacific focused on key therapy areas, promising approved products, technologies and regional product approval agencies/guidelines. 
  • Analysis of key medical conditions that drive biotechnology based research and drug development, comparison with available standard hormonal/chemical treatments for the same.
  • Company focused evaluation of major players in the industry - forecasts and business strategies.
METHODOLOGY AND INFORMATION SOURCES
 
The sales data included is sourced from publicly available documents. Products whose sales data is not disclosed by companies have not been included in estimates and forecasts.
 
 
ASSUMPTIONS 
 
While projections can only be as good as the data available to calculate them, certain assumptions must still be made even with reliable data. The assumptions that are implicit in a forecasting model profoundly influence the forecasts. Our analysis is based on the following assumptions:
  • The products included in the estimations and forecasts are the major drivers of the market. 
  • Sales data from the previous years was reviewed assuming that the past trends will continue in the future. 
  • Where sales data for a full year was unavailable an estimate of the full year sales was made.
The criteria for including companies in this review are: the companies have to be publicly traded, have to involve in R&D of human therapeutics derived from biological substance, have to apply genetic engineering, molecular biology, structural chemistry, rational drug design or rDNA technology. Companies dedicated to developing testing equipments or assays are excluded.
 
Company and product information in this review was assimilated from company-provided documents including annual reports, form 10-K, press reports, and government websites such as SEC and FDA. Discussions with company executives and managers are also a part of the review. Key information on commercial potential and market sizes was obtained from industry professionals.
 
The technological information and analysis presented in this review is based on a detailed examination of published literature and reports obtained from regulatory authorities, medical research institutions, pharmaceutical trade associations, and national and world health organizations.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: BIOTECHNOLOGY IN HEALTHCARE:PRODUCT AND MARKET REVIEW163Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY 3Free
Chapter- 3: OVERVIEW11Free
Chapter- 4: FOCUS OF DRUG DISCOVERY IN BIOTECHNOLOGY7Free
Chapter- 5: ENABLING TECHNOLOGIES10Free
Chapter- 6: BIOTECHNOLOGY BASED PRODUCTS IN HEALTHCARE72Free
Chapter- 7: BIOTECHNOLOGY BASED PRODUCTS IN HEALTHCARE: MEETING THE NEEDS OF CHRONIC DISEASES16Free
Chapter- 8: GLOBAL BIOTECHNOLOGY INDUSTRY21Free
Chapter- 9: MERGERS AND CORPORATE DEALS: DO THEY PAY OFF?4Free
Chapter- 10: C. CRAMER & CO. GMBH15Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report:

Sample Report

Recent Reports

Global Healthcare Fraud Detection Market

Published - Jun 2026 | Publisher - BCC Publishing | Code - HLC316A

This report provides a brief general outlook of the global healthcare fraud detection market. It includes global revenue ($ million) for base year data of 2024, estimated data of 2025, and forecasts through 2030. The report focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.

Global Orthopedic Surgical Robots Market

Published - May 2026 | Publisher - BCC Publishing | Code - HLC310A

The global market for orthopedic surgical robots was valued at $2.7 billion in 2025 and is expected to reach $4.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2030.

Chronic Kidney Disease: Global Markets and Technologies

Published - May 2026 | Publisher - BCC Publishing | Code - HLC214B

The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.

State of the Life Sciences Industry - 2026 First Quarter Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - HLC314C

Explore BCC Research’s Q1 2026 review of the life sciences industry, covering market trends, innovation, sector performance, and growth outlook.

Noninvasive Cancer Diagnostics: Technologies and Global Markets

Published - Mar 2026 | Publisher - BCC Publishing | Code - HLC197B

The global market for noninvasive cancer diagnostic technologies is expected to grow from $119.9 billion in 2025 and is projected to reach $165.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.6% during the forecast period of 2025 to 2030.

Top Trending Reports

2025 Medical Devices Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - MDS060C

Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.

Cancer Profiling and Pathways: Technologies and Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - BIO073D

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Glass Fiber: Global Markets

Published - May 2026 | Publisher - BCC Publishing | Code - AVM225B

The global market for glass fiber is expected to grow from $13.5 billion in 2026 and is projected to reach $17.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2026 to 2031.

2025 Chemical Research Review

Published - Apr 2026 | Publisher - BCC Publishing | Code - CHM190B

BCC Research’s 2025 Chemical Research Review covering market trends, specialty chemicals, industrial innovation and growth opportunities across the chemical industry.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
BIOTECHNOLOGY IN HEALTHCARE:PRODUCT AND MARKET REVIEW
Customize Report
AI Sentiment